Signify Premium Insight: COVID-19’s Impact on the Imaging IT Market
Published: February 9, 2021
As with almost every other market sector, Imaging IT has not escaped the effects of the global COVID-19 pandemic. However, different regions, different healthcare systems and different stakeholders have all been impacted in different ways.
These consequences are comprehensively detailed and quantified in Signify Research’s recent Scenario Commentary, as part of the Imaging IT Intelligence service. There are several key insights that can be gleaned which have wider implications for the medical imaging industry.
Overall, imaging IT has emerged through the worst of the COVID-19 pandemic relatively unscathed. The closing of deals discussed prior to 2020 helped to buoy the market, along with additional spending from healthcare providers to support COVID-19 pandemic response plans. However, the worst may be yet to come, with initial reports suggesting relatively weak deal pipeline for 2021, in part due to the second-wave response from healthcare provider delaying new contract discussion. At the time of writing, we see 2021 as the likely bottom of the market